Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Navamedic ASA ( (DE:N1A) ) has shared an announcement.
Navamedic ASA announced the expiration of trading for subscription rights in its rights issue, with the subscription period closing on October 6, 2025. The rights issue involves the issuance of up to 6,046,511 new shares at a price of NOK 21.50 per share, and any unsold or unexercised rights will lapse without compensation, potentially impacting shareholder value and market dynamics.
More about Navamedic ASA
Navamedic ASA is a full-service provider of high-quality healthcare products catering to hospitals and pharmacies. The company leverages a scalable market access platform and local knowledge to meet specific medical needs across the Nordic countries, the Baltics, Benelux, and Greece. Headquartered in Oslo, Norway, Navamedic is listed on the Oslo Stock Exchange.
Average Trading Volume: 15,422
Current Market Cap: NOK509.7M
For an in-depth examination of N1A stock, go to TipRanks’ Overview page.